Xoma | L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
AbbVie USD 4.38B 1.92B 2025-09
Agenus USD -274.14M 80.46M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Ardelyx USD -867K 18.21M 2025-09
aTyr Pharma USD -25.75M 6.22M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Celldex Therapeutics USD -67.04M 10.44M 2025-09
Curis USD -13.99M 7.38M 2025-06
Eli Lilly USD 7.23B 456M 2025-09
Incyte USD 482.31M 75.7M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
Novartis USD 4.2B 335M 2025-09
Novartis USD 5.17B 637M 2025-09
Pfizer USD 3.33B 290M 2025-09
Prothena USD -36.91M 44.05M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Xoma USD 15.98M 24.58M 2024-06


Xoma L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.